KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCA Healthcare (HCA) Share-based Compensation (2016 - 2025)

HCA Healthcare (HCA) has disclosed Share-based Compensation for 16 consecutive years, with $100.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Share-based Compensation rose 17.65% to $100.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $401.0 million, a 11.39% increase, with the full-year FY2025 number at $401.0 million, up 11.39% from a year prior.
  • Share-based Compensation was $100.0 million for Q4 2025 at HCA Healthcare, down from $104.0 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $129.0 million in Q2 2021 to a low of $56.0 million in Q2 2023.
  • A 5-year average of $90.2 million and a median of $87.0 million in 2022 define the central range for Share-based Compensation.
  • Peak YoY movement for Share-based Compensation: crashed 34.12% in 2023, then skyrocketed 100.0% in 2024.
  • HCA Healthcare's Share-based Compensation stood at $99.0 million in 2021, then decreased by 16.16% to $83.0 million in 2022, then tumbled by 31.33% to $57.0 million in 2023, then skyrocketed by 49.12% to $85.0 million in 2024, then increased by 17.65% to $100.0 million in 2025.
  • Per Business Quant, the three most recent readings for HCA's Share-based Compensation are $100.0 million (Q4 2025), $104.0 million (Q3 2025), and $99.0 million (Q2 2025).